Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma

Published:2023-01-25 Issue:7 Volume:107 Page:1434-1435
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Lerut Jan¹,Lai Quirino²

Affiliation:

1. Institut de Recherche Clinique et Expérimental, Université Catholique de Louvain, Brussels, Belgium.

2. General Surgery and Organ Transplantation Unit, Department of General and Specialistic Surgery, Sapienza University of Rome, AOU Policlinico Umberto I of Rome, Rome, Italy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference16 articles.

1. Hepatocellular cancer selection systems and liver transplantation: from the tower of Babel to an ideal comprehensive score.;Lerut;Updates Surg,2021

2. Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?;Lerut;Transl Gastroenterol Hepatol,2017

3. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors reassessment of risk factors for tumor recurrence.;Vivarelli;Ann Surg,2008

4. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma.;Vivarelli;Transplantation,2010

5. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.;Rodríguez-Perálvarez;Am J Transplant,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review;Hepatobiliary & Pancreatic Diseases International;2024-04